melatonin has been researched along with Nocturia in 11 studies
Nocturia: Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sixty women with nocturia, aged > 55 years, were prospectively recruited and were later randomly allocated to treatment (melatonin 2 mg/day, n = 30) and control (placebo, n = 30) arms for 2 weeks." | 9.69 | Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial. ( Asumpinwong, C; Hengrasmee, P; Leerasiri, P; Pariyaeksut, P, 2023) |
| "This study showed that adding melatonin to the classic treatment of BPH patients with tamsulosin could significantly reduce the likelihood of nocturia by 2." | 9.51 | The effect of Melatonin on Improving the benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial. ( Ayati, M; Fotovat, A; Momeni, SA; Nasseri, A; Nowroozi, MR; Samadzadeh, B; Sharifi, L; Yavari, S, 2022) |
| "From the 26 patients who completed the study, there was no significant difference observed in the signs or symptoms of nocturia when taking 2 mg melatonin compared to placebo." | 9.27 | Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS). ( Canham, L; Cotterill, N; Cottrell, D; Delgado, D; Drake, MJ; Homewood, J; Inglis, K; Johnson, L; Kisanga, MC; Owen, D; White, P, 2018) |
| "This study will evaluate whether melatonin reduces the frequency of nocturia episodes in MS patients, and therefore whether 'Circadin' has the potential to reduce LUTS and fatigue, and improve cognition and overall quality of life." | 9.24 | Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS). ( Canham, L; Cotterill, N; Cottrell, D; Delgado, D; Drake, MJ; Inglis, K; Owen, D; White, P, 2017) |
| "Univariate comparisons between the 261 and 600 study participants with and without nocturia, respectively, showed marginal to significant associations of nocturia with age, gender, body mass index, estimated glomerular filtration rate, calcium channel blockers, benign prostatic hyperplasia, total voided urine volume, urinary 6-sulfatoxymelatonin, duration in bed, day length, and daytime and nighttime physical activity." | 7.80 | Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. ( Kurumatani, N; Obayashi, K; Saeki, K, 2014) |
| " Sixty women with nocturia, aged > 55 years, were prospectively recruited and were later randomly allocated to treatment (melatonin 2 mg/day, n = 30) and control (placebo, n = 30) arms for 2 weeks." | 5.69 | Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial. ( Asumpinwong, C; Hengrasmee, P; Leerasiri, P; Pariyaeksut, P, 2023) |
| "Nocturia is one of the commonest non-motor symptoms in Parkinson's disease (PD)." | 5.62 | Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease. ( Baldwin, J; Batla, A; Bhatia, KP; deMin, L; Eriksson, S; Islam, S; Melbourne, C; Pakzad, M; Panicker, JN; Simeoni, S; Uchiyama, T, 2021) |
| "This study showed that adding melatonin to the classic treatment of BPH patients with tamsulosin could significantly reduce the likelihood of nocturia by 2." | 5.51 | The effect of Melatonin on Improving the benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial. ( Ayati, M; Fotovat, A; Momeni, SA; Nasseri, A; Nowroozi, MR; Samadzadeh, B; Sharifi, L; Yavari, S, 2022) |
| "From the 26 patients who completed the study, there was no significant difference observed in the signs or symptoms of nocturia when taking 2 mg melatonin compared to placebo." | 5.27 | Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS). ( Canham, L; Cotterill, N; Cottrell, D; Delgado, D; Drake, MJ; Homewood, J; Inglis, K; Johnson, L; Kisanga, MC; Owen, D; White, P, 2018) |
| "This study will evaluate whether melatonin reduces the frequency of nocturia episodes in MS patients, and therefore whether 'Circadin' has the potential to reduce LUTS and fatigue, and improve cognition and overall quality of life." | 5.24 | Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS). ( Canham, L; Cotterill, N; Cottrell, D; Delgado, D; Drake, MJ; Inglis, K; Owen, D; White, P, 2017) |
| "Univariate comparisons between the 261 and 600 study participants with and without nocturia, respectively, showed marginal to significant associations of nocturia with age, gender, body mass index, estimated glomerular filtration rate, calcium channel blockers, benign prostatic hyperplasia, total voided urine volume, urinary 6-sulfatoxymelatonin, duration in bed, day length, and daytime and nighttime physical activity." | 3.80 | Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. ( Kurumatani, N; Obayashi, K; Saeki, K, 2014) |
| "The features specific to the elderly nocturia group are as follows: (1) a decrease of the nighttime plasma melatonin level, (2) an increase of nighttime plasma catecholamine levels, (3) an increase of daytime and nighttime plasma natriuretic peptide levels, (4) an increase of blood pressure, (5) a decrease of daytime and nighttime urinary osmotic pressure, (6) an increase of total urine volume, and (7) an increase of the edema ratio before sleeping." | 3.74 | Biochemical and body composition analysis of nocturia in the elderly. ( Miyazato, M; Nishijima, S; Oda, M; Ogawa, Y; Owan, T; Sugaya, K, 2008) |
| "Melatonin could be beneficial in the treatment of nocturia and other common bladder disorders." | 3.01 | Role of circadian rhythms and melatonin in bladder function in heath and diseases. ( Ramsay, S; Zagorodnyuk, V, 2023) |
| "Nocturia is one of the commonest non-motor symptoms in Parkinson's disease (PD)." | 1.62 | Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease. ( Baldwin, J; Batla, A; Bhatia, KP; deMin, L; Eriksson, S; Islam, S; Melbourne, C; Pakzad, M; Panicker, JN; Simeoni, S; Uchiyama, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Fotovat, A | 1 |
| Samadzadeh, B | 1 |
| Ayati, M | 1 |
| Nowroozi, MR | 1 |
| Momeni, SA | 1 |
| Yavari, S | 1 |
| Nasseri, A | 1 |
| Sharifi, L | 1 |
| Miyake, M | 1 |
| Nishimura, N | 1 |
| Ohnishi, S | 1 |
| Oda, Y | 1 |
| Miyamoto, T | 1 |
| Shimizu, T | 1 |
| Hori, S | 1 |
| Morizawa, Y | 1 |
| Gotoh, D | 1 |
| Nakai, Y | 1 |
| Anai, S | 1 |
| Torimoto, K | 1 |
| Aoki, K | 1 |
| Fujii, T | 1 |
| Tanaka, N | 1 |
| Fujimoto, K | 1 |
| Leerasiri, P | 1 |
| Pariyaeksut, P | 1 |
| Hengrasmee, P | 1 |
| Asumpinwong, C | 1 |
| Ramsay, S | 1 |
| Zagorodnyuk, V | 1 |
| Batla, A | 1 |
| Simeoni, S | 1 |
| Uchiyama, T | 1 |
| deMin, L | 1 |
| Baldwin, J | 1 |
| Melbourne, C | 1 |
| Islam, S | 1 |
| Bhatia, KP | 1 |
| Pakzad, M | 1 |
| Eriksson, S | 1 |
| Panicker, JN | 1 |
| Delgado, D | 2 |
| Canham, L | 2 |
| Cotterill, N | 2 |
| Cottrell, D | 2 |
| Drake, MJ | 2 |
| Inglis, K | 2 |
| Owen, D | 2 |
| White, P | 2 |
| Homewood, J | 1 |
| Johnson, L | 1 |
| Kisanga, MC | 1 |
| Obayashi, K | 1 |
| Saeki, K | 1 |
| Kurumatani, N | 1 |
| Diaz, M | 1 |
| Wolkove, N | 1 |
| Elkholy, O | 1 |
| Baltzan, M | 1 |
| Palayew, M | 1 |
| Sugaya, K | 1 |
| Nishijima, S | 1 |
| Oda, M | 1 |
| Owan, T | 1 |
| Miyazato, M | 1 |
| Ogawa, Y | 1 |
2 reviews available for melatonin and Nocturia
| Article | Year |
|---|---|
Role of circadian rhythms and melatonin in bladder function in heath and diseases.
Topics: Aged; Circadian Rhythm; Humans; Melatonin; Nocturia; Suprachiasmatic Nucleus; Urinary Bladder | 2023 |
Sleep and aging: 2. Management of sleep disorders in older people.
Topics: Adjuvants, Immunologic; Aged; Aging; Antidepressive Agents; Behavior Therapy; Benzodiazepines; Demen | 2007 |
4 trials available for melatonin and Nocturia
| Article | Year |
|---|---|
The effect of Melatonin on Improving the benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial.
Topics: Double-Blind Method; Humans; Male; Melatonin; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonam | 2022 |
Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial.
Topics: Aged; Double-Blind Method; Female; Humans; Melatonin; Nocturia; Outcome Assessment, Health Care; Qua | 2023 |
Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).
Topics: Adult; Central Nervous System Depressants; Clinical Protocols; Cross-Over Studies; Double-Blind Meth | 2017 |
Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Melatonin; Middle Aged; | 2018 |
5 other studies available for melatonin and Nocturia
| Article | Year |
|---|---|
Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.
Topics: Administration, Intravesical; BCG Vaccine; Creatinine; Humans; Male; Melatonin; Neoplasm Invasivenes | 2022 |
Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease.
Topics: Adult; Aged; Delayed-Action Preparations; Humans; Male; Melatonin; Nocturia; Parkinson Disease; Pilo | 2021 |
Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort.
Topics: Aged; Biomarkers; Circadian Rhythm; Cross-Sectional Studies; Female; Humans; Incidence; Japan; Male; | 2014 |
Editorial comment.
Topics: Circadian Rhythm; Female; Humans; Male; Melatonin; Nocturia; Urinary Bladder; Urination | 2014 |
Biochemical and body composition analysis of nocturia in the elderly.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Pressure; Body Composition; Catecholamines; Circadian Rh | 2008 |